DTP reactions and serologic response with a reduced dose schedule

Area of Science:

• Pediatrics
• Immunology
• Vaccinology

Background:

• The DTP (diphtheria, tetanus, and pertussis) vaccine is crucial for infant immunization.
• Standard DTP vaccine doses can cause significant side effects, prompting research into modified regimens.
• Evaluating vaccine efficacy and safety in infant populations is essential for public health.

Purpose of the Study:

• To compare the safety and immunogenicity of a standard versus a modified DTP vaccine dose in infants.
• To assess side effects, including febrile reactions, behavioral changes, and local reactions.
• To determine antibody responses against diphtheria, tetanus, and pertussis.

Main Methods:

• A double-blind study involving infants receiving either standard (0.5 ml) or modified (0.25 ml) DTP vaccine doses.
• Immunizations were administered for the primary series at 2, 4, and 6 months, and a booster at 18 months.
• Side effects and antibody titers were monitored in 80 children for the primary series and 73 for the booster.

Main Results:

• The modified DTP vaccine regimen significantly reduced febrile reactions and behavioral changes compared to the standard dose.
• Local reaction incidence was lower with the modified dose during the primary series but similar for the booster.
• All infants achieved protective antibody titers for diphtheria and tetanus; pertussis titers were comparable and protective, with one standard-dose recipient falling below the threshold post-booster.

Conclusions:

• A modified, reduced DTP vaccine dose is a safer alternative, showing fewer adverse reactions in infants.
• The modified DTP vaccine regimen maintains adequate serologic protection against diphtheria, tetanus, and pertussis.
• This modified DTP vaccine approach offers a promising strategy for improving infant vaccination safety without compromising immunogenicity.